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J 1029-1513 Coronary Stentlng In Acute Myo.rdlal 
Infarction With Cardlogenl© Shock 
1", Lefevm, M,-C. Mort~, G, Kamllon, M, Krol, Y. Louvem, P, Ouma~, 
B, Abry, J,F, Angellmr, J,.K V~etaira, ICPS, M~$sy, Franc~ 
Back~*  C4z~+ .t~q~. llllOCk In ar, utO MI is us~)¢ial~i ~th a high mort~ity 
rate even after suco)~ful PTCA. 
M#l~hod~: The pgq~0~ of this Sh~ w~ to evaluate th~ lo f lg~ of 
OXlmlziN~ mm of ¢+~m~my M0fltmg (=nag 01/95) in ~ tmfling~ 
R#m,r/~' Ot+1 of 393 AMI pl$ odm~ttod within 12 ho~r~ atl~r th0 onset 
of MI, Sl (t2,G%) ~ in ¢~rd~gm~ ehod~ Me~t ~o w~ 70 ~: 13 ym 
(31% f~m~k~), MI wa~ I~blft~, in ~% of r ,~¢ IRA was LAD in §t%, loft 
n~in t§%, RC.~ 2S% ~d Ci¢ in t~ Of ¢~.  Procedural 5ucc~s was 
Obteu!~ in 00% of ~ (~tOmtt: 71PPe, proced~Jr+ll eiur.~ess; 97%) with 34 
t0 m door tO litlmt ~ TI~ in , l~ l  ,J:o~n~ was; t (~+) ft~4~t PTCA 
to nd!~ (~4 hours; 22% w ~,4 ho~ 62%_. p ~ 0,069) P.nd by a i~i~ng 
I~, wt4h _1~ !~1 t19-'~:,~) 19110+t%) 19 (I~.P,,) 
~t~l  ~ (%) ~3~ 695 73.7 
~ (%1 033 89 5 944 
I[~k~t~ s=tera (m~n) 40 ~ ~.JZ 3~: 10 29± +;~ 
tn -~ dmt, m f%) 5~ 5 57.9 43.4 
C ~ :  C,~o~_ I~b~tlm~ m AMI wttkt cae~f t i c  shock is as_ ~la.tecJ 
a high pm¢t~km~ ~orm<m ,ate. Stenm~ rate as we, as pnx:e~r~ 
dumlian and su~mms me influenoed by a learning ctmre. ~mo to admissmn 
iS the most pmdiclive f~"tor Of n'ol~ity. 
i02~is21 oimmm~s in pau~t= With ~ aWr.ard~= 
' ' !nfatrcUon Treated Wlth PHmary .~HmOiopia.My Or 
Thmmbo~/t!¢ Therapy? 
R. Zahn ~ , S. Schustm ~ , R Sch~e~, G. Berg ~, 1". Vo~gti~xleP, M. Gottwi~, 
J. Senges ~ . F~r de MIrRA Studien Gmppe, G~many: ~ Ludwigshaten, 
G ~  a~j ,  Germany; :~Mair~, Gen'nany: +Numberg, Germany 
Background: Prtma~ angmplasty (PA) is an alternative to thrombetys~s (TL) 
in the tmwment of acute myec~rdlal infarclJon (AMI). Howe~er liffie is known 
abOUt he differences in clinical pre.ctice in patients (pts) with AMI treated with 
one oHhe two therapies. 
Methods and Results: 5869 pts with AMI were registered by the MITRA 
study. 477 (8.196) pts were treated with PA and 2810 (47.9%) pts with TL 
Pts treated with PA were younger and had had higher rate of previous MI 
(19% vs. t5.2%, p .= 0.039). Pre-hosp,lal delay time was longer in the PA 
grOup (161 vS. 120 minutes, p = 0.001) as wall as door to treatment brae 
(85 vs. 30 minutes; p = 0.001). Pts lreated w~th PA received more often 
F-blockers (64.~+ vs. 58.1%, p = 0.008), hep~n (98.1% vs. 91.4%, p = 
0.001), ACE inhibitors (63~9% vS. 50%, p = 0.001) and the so called "optimal" 
medication (55.6% vs. 43, p = 0.001). There was a reduction in the incidence 
of heart failure for pts treated with PA (5.5% vs. 16.4%, p = 0.00 t ), post infarct 
angina (7.1% vs. 16.3.°.o, p = 0.001) and in-hospilal death (8% vs. 11.7%, p 
= 0.017). However multivariate anaiys~s revealed only "optimal" concomitant 
medication (OR = 0.77, p = 0.0001), but not the type of mvasculanzation 
(0.85, p = 0.1013) to be associated with a signifmant reduction in the death 
rate. 
Conclusions: In clinical practice ptS treated with PA receive more often 
/+-blockers and ACE inhibitors, which Contribute tO a great pad to the overall 
reduction in mortality, overt head failure and post infarct angina in these pts 
as compared to pts treated with TL 
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Infarction: Angiographic and Clinical Outcome 
in 1179 Patients 
F.W. Bar, R. Aalbregt, K. Neven, J, Frederiks, A.J. Oude Ophuis, H.B. de 
Swart, J. Valner, HJ.J. Wellens. Department of Cardiology, University 
Hospital Maastrichf, Maasfficht, The Netherlands 
Background: Angiogmphic and clinical outcome tn 1179 consecutive pa- 
tients with acute myocardial infarction (AMI) were analyzed. These patients 
were all admitted to the University Hospital Maastricht over a 10 year period 
(1986-1997). Since 1992, apart from patients primarily admitted to this hospi- 
tal also patients were sent by surrounding hospitals, 487 Patients had rescue 
angiuplasty (RA) and 692 patients had primary angioplasty (PA). Nearly all 
patients had the intervention within 90 minutes after admission. In patients 
where thrombotysis was given, rescue PTCA was performed if this therapy 
did not reperfuse the artery within 60-75 minutes. 
ABSTRACTS ~ Po~tcr 95A 
ReSults: Basolin~ elate were compar~ I~tw~,n RA and PA A~ ot 
I~ti@nls mc(~sod in time: from 57 y~r~ up t0 1992 to 61 yews ~in¢~ I 
PWenoy rates of RA and PA were s,miter: 88%, Patot~ =~tcn~lj~t trom 86% 
inltiatty to 90%, probably ~g~ to tl~ use of =lent~, Inq~os~l ¢o~t!~ 
wera n4~rly simdar lot RA M~ PA v~th sthckwlg low ~! I ty  (3,7%), 0~ 
~PPTCA W~li mo~ fft~u~lt in FIA (11% v~ 7%; p ~ 0,0~), Ot~ ~ ogCon~ 
we~ ~ (ovmalt mo~tdity 5,8%)./~ain, no m~ ~tfw¢~¢~ m k~l  ~rm 
flint yea~ a~r AMI w~m ~ og~, left mare ~t~ ocdu~,o~, f~ l~ ~io~ 
and inl~p~ ize, 
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in th~ l~r~t y~r alter AML 
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[ 103~i251 The l.flu~n~ t Thrombolytlc Tlmmpy =n the 
..... Lon~plerm Pn~l i¢~ Vl~llJ~ of  Exer(:ise Tnt lng  
Infar,~lon 
L. At~ou~, J. H~r, I. Emen, W. ~ ~ M~al  Center. 
TechtuO~, Hails, Ist;~et 
Back~-  The USefulness of po~formlng exercise testing (ET) ~dy after 
acWe m y ~  infamtion (AMI) for pr~;~ting the Ioeg-term pr0gn~Js in 
patients treated in the ttm~nboly1~c era ~ not t~en estal~lisl~ed. 
Methods: 446 consecutive IPatierrts (pts) ~i~¢'h@rl~ from or~ CoronaP/ 
Care Unit and etigib~e for ET 3 weeks_ post-AMl were evalu~ale~ prospect~ely 
and followed for 6 years. 263 pts received thm~is  and 183 ~d not- The 
2 groups w~e not randomized and had different baseline cbera~enst~cS. 
Results: In pa~ts  receNmg thrombely=s subsequent cardiac de~th was 
related to diabetss bu1 to no ET-re Wed parameter ~i multivanate analysis. 
Recurrent AMI could not be related tO any parameter 5hJdied. Need for 
revascularization was misted to post-infarctmn an~na, use of calcium an- 
tagonists and >_2 mm ST-T segment depression dunog ET. In palzentS not 
rece~ thromboI,F,~s, cardiac death was related 1o reduced left ventnCular 
funcbon at discharge and 2 ET.related parameterS: low functional capacity 
and _>2 mm ST-T segment depression. Recurrent AMI was not predicted by 
any vanable studied. Need for revasculanzation was related to low Norris 
Index, non-stunk.rag status, use ot bela-bloCkers, calcaum a~'~tagortl~ts and 
post-mfarcl~on a gina. 
Conclusion: In a population treated by thmml3olysis for AMI. ET-parame- 
ters measured 3 weeks post-AMI have little value for predict,ng supplement 
~ l  events during a 6-years follow,up period. ET-mlated parameters cor- 
related signifmantly with the per/ormance af subsequent revascularization 
procedures. In the population no1 treated with thmmbolysis, ET<tsnved pa- 
remeters were signircanfty correlated w~th cardiac ~eath but not to recurrent 
AML 
I 1030-1261 NO Reflow Phenomenon as a Predictor of  
t - '~  COmplications in the Chronic Stage of 
Reperfusecl Acute Myocardial Infarction 
K. Sugimoto, H. [tO, K Iwakura, N Nishikawa, K. Hiraoka. Y. Higashino, 
K. Fuid. Sa.=cu.,abashi Watanabe Hospital, Osaka, Japan 
Background: We previously reported that no inflow phenomenon at cOronan/ 
reflow can discnminate those with poor functional and ctinical outcomes 
during hospitalization from those with favorable outcomes, In this study, we 
invest=gated whether this phenomenon can also predict clinical outcomes 
and LV mmodedng in the chronic stage of AMI 
Methods: We performed myocardial contrast echocardiegraphy (MCE) in 
the 83 patients with an anterior wall AMI after PTCA. We performed 2-D 
echocardiography atday-1 and 3 months later to determine the end-diastolic 
LV ~iameter (LVDd). We ~so assessed clinical events such as heart failure, 
malignant arrhythmiaso coronary interventzon and cardiac death nuring the 
follow up penod (32.2 ± 16.1 months). 
Results: MCE no reflow was observed in 41 patients (Group 11. while 
the other 42 patients manifested MCE inflow (Group 2). LVDd signicantly 
increased from day-1 to 3 months later in Group 1 (54 ± 4 to 56 - 5 rnm 
p < 0.05) but not in Group 2. We observed heart failure in four patients and 
cardiac death in six pat(ents in Group 1 but in none of Group 2 (p < 0.05). 
There were nO dilferences in the incidence of malignant arrhythmias and 
coronary intervention between two groups. 
